Compile Data Set for Download or QSAR
Report error Found 534 Enz. Inhib. hit(s) with all data for entry = 12857
TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734140(3-(5-(furan-2-yl)pyridin-3-yl)phenyl octylcarbamat...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734155(3-(5-(1,3,4-oxadiazol-2-yl)pyridine-3-yl)phenyl oc...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734219(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-fluorop...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734074(3-(5-(furan-2-yl)pyridin-3-yl)phenyl octylcarbamat...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734154(3-(5-(1,3,4-oxadiazol-2-yl)134 pyridine-3-yl)pheny...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734250(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-4-hydrox...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734031(ethyl 5-(3-((tetradecylcarbamoyl)oxy)phenyl)nicoti...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734191(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-methoxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734287(3-(6-(1,3,4-oxadiazol-2-yl)pyrazin-2-yl)phenyl oct...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734237(3-(5-(1,3,4-thiadiazol-2-yl)pyridin-3-yl)-4-methox...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734036(methyl 5-(3-((heptylcarbamoyl)oxy)phenyl)nicotinat...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734100(3-(5-(oxazol-2-yl)pyridin-3-yl)phenyl octylcarbama...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734180(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-hydroxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734099(3-(5-(oxazol-2-yl)pyridin-3-yl)phenyl heptylcarbam...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734131(3-(5-(isoxazol-5-yl)pyridin-3-yl)phenyl octylcarba...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734243(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)phenyl oc...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734184(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734280(3-(4-(1,3,4-oxadiazol-2-yl)pyridin-2-yl)phenyl hep...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734135(3-(5-(isoxazol-5-yl) pyridin-3-yl)-4-methoxyphenyl...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734231(3-(5-(1,3,4-thiadiazol-2-yl)pyridin-3-yl)phenyl oc...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734198(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-methoxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734037(methyl 5-(3-((octylcarbamoyl)oxy)phenyl)nicotinate...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734181(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-hydroxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734051(3-(5-(hydroxycarbamoyl)pyridin-3-yl)phenyl tetrade...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734156(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl dod...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734153(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl hex...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734161(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl cyc...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734158(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl (cy...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734157(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl tet...)
Affinity DataIC50: 20nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734113(4-fluoro-3-(5-(oxazol-2-yl)pyridin-3-yl)phenyl cyc...)
Affinity DataIC50: 23.9nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734189(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 25.8nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734091(3-(5-(thiophen-2-yl)pyridin-3-yl)phenyl cyclohepty...)
Affinity DataIC50: 39.1nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734218(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-fluorop...)
Affinity DataIC50: 49.1nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734284(3-(4-(1,3,4-oxadiazol-2-yl)pyridin-2-yl)phenyl cyc...)
Affinity DataIC50: 50.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734188(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734059(3-(5-(trifluoromethyl)pyridin-3-yl)phenyl cyclopen...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734187(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734058(3-(5-(trifluoromethyl)pyridin-3-yl)phenyl (cyclohe...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734057(3-(5-(trifluoromethyl)pyridin-3-yl)phenyl octylcar...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734185(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734256(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-4-methox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734062(3-(5-(1H-pyrrol-2-yl)pyridin-3-yl)phenyl octylcarb...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734190(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-methoxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734253(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-4-hydrox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734244(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)phenyl (c...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734114(3-(5-(oxazol-2-yl)pyridin-3-yl)-4-(trifluoromethox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734242(3-(5-(1,3,4-thiadiazol-2-yl)pyridin-3-yl)-4-methox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734183(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734054(3-(5-cyanopyridin-3-yl)phenyl octylcarbamate | US2...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandPNGBDBM734246(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)phenyl (n...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

Displayed 1 to 50 (of 534 total ) | Next | Last >>
Jump to: